Drug
VX 135
VX 135: highest development phase Phase 2, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-135 NCT01842451 | Phase 2 | Chronic Hepatitis C |
Latest
No recent events.
Follow VX 135 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.